Welcome to
New Medical Technologies
About INSTI Rapid Tests
INSTI rapid diagnostic tests are developed by bioLytical Laboratories Inc., a Canadian biotechnology company specializing in innovative rapid testing technologies for infectious diseases. The INSTI platform enables fast and reliable antibody detection using a simple procedure and delivers results in approximately one minute.
Manufacturer
bioLytical Laboratories Inc.
Canada
Technology
Rapid antibody detection platform
Result Time
Approximately 60 seconds
HIV-1 / HIV-2 Antibody Test
A professional rapid screening test designed for healthcare providers and laboratories. The test detects antibodies to HIV-1 and HIV-2 with high accuracy.
The platform allows fast diagnostics and supports screening programs in clinical and outreach settings.
INSTI HIV Self Test
A rapid HIV self-screening test designed for individual use. The test delivers reliable results in approximately one minute using a simple fingerstick blood sample.
The test is designed to support early detection and improve access to HIV testing in a convenient and private environment.
HIV / Syphilis Multiplex Test
A dual rapid screening test designed to detect HIV-1, HIV-2 and syphilis antibodies simultaneously using a single sample.
This multiplex solution enables efficient screening in clinics, laboratories and public health testing programs.
HCV Antibody Test
A rapid diagnostic test designed to detect antibodies to Hepatitis C virus. Early detection enables timely treatment and improved patient outcomes.
The test supports screening programs aimed at identifying individuals with chronic Hepatitis C infection.
Key Advantages
60 seconds
Test results are available in approximately one minute, enabling rapid clinical decision making.
>99% accuracy
Clinical evaluations demonstrate high diagnostic accuracy for antibody detection.
Simple procedure
Testing requires only a small blood sample and minimal training.
Point-of-care use
Suitable for hospitals, clinics, laboratories and outreach programs.
Global adoption
INSTI tests are used worldwide in clinical and public health screening programs.
Official Manufacturer Authorization
bioLytical Laboratories Inc., the Canadian manufacturer of INSTI rapid diagnostic tests, has officially authorized the distribution and registration of these products in Hungary.
This authorization confirms the partnership with International Supply Solutions Kft. and permits the commercial distribution of INSTI HIV, HIV Multiplex, HCV and Self-Test products within the Hungarian market.
View AuthorizationSoftware
Warehouse
